Contour Therapeutics Brings Together Leaders with Extensive Cardiovascular, Genetics and Drug Development Expertise Partnership Focused on Delivering Targeted Therapies for Genetically Defined Cardiovascular Diseases PALO ALTO, Calif. and SOUTH SAN FRANCISCO, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) and Maze Therapeutics today announced the establishment of a joint venture, Contour Therapeutics, focused […]
Financial
Matinas BioPharma Files Preliminary Proxy for Special Meeting of Stockholders
– Special Meeting of Stockholders Scheduled for January 26, 2021 Seeking Authorization to Potentially Effectuate a Discretionary Reverse Stock Split Prior to January 26, 2022 – – Company’s Proposal to Stockholders Intended to Enhance Appeal of Common Stock to Institutional Investors, Position its Common Stock for Potential Eligibility for Inclusion in Certain Biotechnology and Pharmaceutical Trading Indices and for Potential Inclusion on the NYSE “Big Board” or NASDAQ Global Market – BEDMINSTER, N.J., Dec. 07, 2020 (GLOBE NEWSWIRE) — Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), […]
Basking Biosciences, Inc. Completes $5.4M Seed Financing
Funding to support development of the first reversible thrombolytic therapy for acute ischemic stroke COLUMBUS, Ohio–(BUSINESS WIRE)–Basking Biosciences, Inc. (Basking), a privately-held biopharmaceutical company developing a next generation treatment for acute ischemic stroke (AIS) announced an initial closing of a $5.4M Seed Series financing. The investor syndicate includes Rev1 Ventures, […]
ROSEN, A TOP RANKED LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Boston Scientific Corporation – BSX
NEW YORK–(BUSINESS WIRE)–Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Boston Scientific Corporation (NYSE: BSX) between April 24, 2019 to November 16, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages […]
Silk Road Medical Announces Changes to Board of Directors
SUNNYVALE, Calif., Dec. 03, 2020 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the appointment of Kevin Ballinger to the company’s Board of Directors. Simultaneously, the company also announced the resignation of current board […]
Issuance of new shares in Mentice AB (publ) has been registered with the Swedish Companies Registration Office
STOCKHOLM, Dec. 4, 2020 /PRNewswire/ — Regarding the acquisition of the assets from Vascular Simulations Inc 571,974 shares have been issued at a subscription price of SEK 86.16 and regarding the acquisition of the assets from EQIP Inc, 9,469 shares have been issued at a subscription price of SEK 84.28. The total number of shares […]
OMRON strengthens engagement with AliveCor with E-series investment
– OMRON reinforces its involvement with AliveCor with E-series investment and strengthens the alliance between the companies for the remote management of cardiovascular conditions KYOTO, Japan, Dec.4, 2020 / PRNewswire / – OMRON Healthcare Co., Ltd. announced on November 24 the additional investment in AliveCor by its parent company, […]
Marizyme, Inc. Expands Executive Team, Board of Directors
Steven Brooks, M.D., MBA, FACC – Appointed EVP of Medical and Regulatory Affairs, Chief Medical Officer Donald Very, Ph.D. – Appointed EVP, Research & Development William Hearl, Ph.D. – Named Independent Member of Board of Directors JUPITER, Fla., Dec. 4, 2020 /PRNewswire/ — Marizyme, Inc. (OTCQB: MRZM), a publicly traded global biotechnology company developing products […]
LivaNova and Gyrus Capital Enter into Agreement for the Purchase of Heart Valve Business
LONDON–(BUSINESS WIRE)–LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, and Gyrus Capital (Gyrus), an investment firm dedicated to investments in the healthcare and sustainability sectors, today announced they have entered into an agreement whereby entities funded and controlled by Gyrus will acquire the LivaNova heart valve (HV) business. […]
BIOMODEX Names Bill Perusek as Vice President of U.S. Sales
Former sales leader at Corindus Vascular Robotics and Boston Scientific joins Biomodex to head up U.S. sales of growing portfolio of 3D printed solutions for patient-specific rehearsal and physician training BOSTON, Dec. 3, 2020 /PRNewswire/ — BIOMODEX®, a pioneering digital health company that offers unique and enhanced 3D printed solutions for patient-specific rehearsal […]
Recent
Popular
- No commented posts yet